SOFIA MIRANDA-PASQUALINI: Open Payments
NPI 1235799727 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,795 in 34 payments from 10 companies in 2025. Trend: 2023 $6,127 · 2024 $3,150 · 2025 $9,795
Consulting: $5,858Travel & lodging: $2,398Food & beverage: $1,536Education: $4
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $9,054 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $197 |
| Teva Pharmaceuticals USA, Inc. | 4 | $191 |
| Alkermes, Inc. | 5 | $179 |
| Supernus Pharmaceuticals, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| USWM, LLC | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: QFITLIA, ALTUVIIIO, CAPLYTA, AUSTEDO XR, LYBALVI, ARISTADA, Qelbree, HETLIOZ.
Industry payments across FL — which companies pay providers there.
